JP2025514180A5 - - Google Patents
Info
- Publication number
- JP2025514180A5 JP2025514180A5 JP2024563257A JP2024563257A JP2025514180A5 JP 2025514180 A5 JP2025514180 A5 JP 2025514180A5 JP 2024563257 A JP2024563257 A JP 2024563257A JP 2024563257 A JP2024563257 A JP 2024563257A JP 2025514180 A5 JP2025514180 A5 JP 2025514180A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate according
- mir
- carbohydrate
- gene sequence
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263335174P | 2022-04-26 | 2022-04-26 | |
| US63/335,174 | 2022-04-26 | ||
| PCT/US2023/019940 WO2023212027A2 (en) | 2022-04-26 | 2023-04-26 | Genetic sequence-carbohydrate conjugates for enhanced liver- and kidney-specific targeting |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025514180A JP2025514180A (ja) | 2025-05-02 |
| JP2025514180A5 true JP2025514180A5 (enExample) | 2026-05-08 |
Family
ID=88519558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563257A Pending JP2025514180A (ja) | 2022-04-26 | 2023-04-26 | 強化された肝臓及び腎臓特異的標的化のための遺伝子配列－炭水化物コンジュゲート |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250346895A1 (enExample) |
| EP (1) | EP4514970A2 (enExample) |
| JP (1) | JP2025514180A (enExample) |
| CN (1) | CN119213006A (enExample) |
| CA (1) | CA3256515A1 (enExample) |
| WO (1) | WO2023212027A2 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6746868B1 (en) * | 1997-09-18 | 2004-06-08 | Isis Pharmaceuticals, Inc. | Chemical modification of DNA using peptide nucleic acid conjugates |
| NZ528966A (en) * | 2003-10-17 | 2006-11-30 | Otago Innovation Ltd | Peptide nucleic acid conjugates and uses thereof |
| EP2229186A2 (en) * | 2007-12-04 | 2010-09-22 | Alnylam Pharmaceuticals Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
| US11833254B2 (en) * | 2020-05-27 | 2023-12-05 | University Of Connecticut | Discoidal nano universal platform for efficient delivery of PNAs |
-
2023
- 2023-04-26 EP EP23797192.4A patent/EP4514970A2/en active Pending
- 2023-04-26 CA CA3256515A patent/CA3256515A1/en active Pending
- 2023-04-26 JP JP2024563257A patent/JP2025514180A/ja active Pending
- 2023-04-26 WO PCT/US2023/019940 patent/WO2023212027A2/en not_active Ceased
- 2023-04-26 US US18/860,452 patent/US20250346895A1/en active Pending
- 2023-04-26 CN CN202380040661.4A patent/CN119213006A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Roberts et al. | Advances in oligonucleotide drug delivery | |
| DK2431466T3 (en) | Single-stranded nucleic acid molecule for the control of gene expression | |
| ES2742654T3 (es) | Oligonucleótidos antisentido modificados hidrofóbicamente que comprenden un grupo cetal | |
| ES2899043T3 (es) | Novedosos conjugados de oligonucleótidos y su uso | |
| CN105705638B (zh) | 改善的具有高效能的纳米颗粒型寡核苷酸结构及其制备方法 | |
| JP2021533804A5 (enExample) | ||
| EP3696269A1 (en) | Single-stranded nucleic acid molecule, and production method therefor | |
| BR112014016562B1 (pt) | Estrutura de oligo-rna de dupla hélice, nanopartícula e método de preparação | |
| WO2021146548A1 (en) | Universal dynamic pharmacokinetic-modifying anchors | |
| EP3550021A1 (en) | Products and compositions for inhibiting expression of a target gene | |
| Ruchi et al. | Evolution of antisense oligonucleotides: navigating nucleic acid chemistry and delivery challenges | |
| JP2023541639A (ja) | 脂肪酸にコンジュゲートしたオリゴヌクレオチド | |
| US11479769B2 (en) | Technique for treating cancer using structurally-reinforced S-TuD | |
| EP4628583A1 (en) | Bicyclic abasic nucleic acid analogs and oligomeric compounds prepared therefrom | |
| EP4323517A2 (en) | Compositions containing nucleic acid nanoparticles and processes related to alteration of their physicochemical characteristics | |
| KR20240072931A (ko) | 히스티딘을 포함하는 지질 나노입자 및 그 제조방법 | |
| US20260028630A1 (en) | Hybrid oligonucleotides | |
| US20250346895A1 (en) | Genetic sequence-carbohydrate conjugates for enhanced liver- and kidney-specific targeting | |
| HK40126008A (en) | Bicyclic abasic nucleic acid analogs and oligomeric compounds prepared therefrom | |
| WO2025223315A1 (zh) | 一种用于肝脏特异性递送的多靶标双链rna偶联物及药物组合物 | |
| HK40115145A (en) | Angiotensinogen-modulating compositions and methods of use thereof | |
| WO2025091026A1 (en) | Therapeutic compositions containing g-clamp pna and uses thereof | |
| JP2025514327A5 (enExample) | ||
| HK40034188A (en) | Single-stranded nucleic acid molecule, and production method therefor | |
| Boos | Development of Whole Body Scanning PCR, a highly sensitive method to study the biodistribution of mRNAs, noncoding RNAs and therapeutic oligonucleotides |